BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) shot up 3.6% on Friday . The company traded as high as $0.17 and last traded at $0.17. 10,000 shares changed hands during mid-day trading, an increase of 237% from the average session volume of 2,963 shares. The stock had previously closed at $0.16.
BioNxt Solutions Price Performance
The company has a market capitalization of $19.28 million, a P/E ratio of -4.25 and a beta of 0.85. The firm has a fifty day moving average price of $0.18 and a 200-day moving average price of $0.21.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Read More
- Five stocks we like better than BioNxt Solutions
- Roth IRA Calculator: Calculate Your Potential Returns
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Top-Performing Non-Leveraged ETFs This Year
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
